Tandem Diabetes Care (TNDM)
Builds software-updatable insulin pumps, cartridges, and infusion sets for diabetes care.
$17.27
After hours−0.23 (−1.34%)
At close$17.50(−0.68%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 186 | 197 | 192 | 222 | 363 | 283 | 234 | 241 | 249 | 290 | 247 | 255 |
| Cost of revenue | 96 | 104 | 97 | 109 | 239 | 125 | 116 | 115 | 115 | 123 | 110 | 110 |
| Gross profit | 90 | 93 | 95 | 113 | 125 | 157 | 118 | 126 | 134 | 167 | 137 | 145 |
| 121 | 128 | 136 | 144 | 151 | 158 | 239 | 178 | 154 | 159 | 154 | 159 | |
| Research & development | 42 | 43 | 46 | 49 | 51 | 52 | 125 | 48 | 48 | 46 | 46 | 47 |
| Selling, general & administrative | 79 | 86 | 90 | 94 | 100 | 106 | 114 | 110 | 106 | 113 | 108 | 112 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20 | 0 | 0 | 0 | 0 |
| Operating income | −32 | −35 | −42 | −31 | −26 | −1 | −121 | −52 | −20 | 8 | −17 | −14 |
| 1 | 4 | 2 | 1 | 3 | 1 | −1 | −6 | −5 | −4 | −2 | −7 | |
| Interest income | 6 | 6 | 5 | 3 | 5 | 5 | 4 | 0 | 3 | 3 | 4 | 1 |
| Interest expense | 5 | 2 | 2 | 2 | 2 | 2 | 1 | 3 | 2 | 2 | 2 | 2 |
| Other non-operating income | −5 | −5 | −4 | −3 | −5 | −2 | 0 | 3 | 3 | 2 | 1 | 4 |
| Income before tax | −31 | −31 | −40 | −30 | −23 | 0 | −122 | −58 | −25 | 5 | −20 | −21 |
| Income tax expense | 2 | −1 | 3 | 1 | 1 | −1 | 8 | −5 | −4 | 5 | 1 | 1 |
| Net income from continuing operations | −33 | −30 | −43 | −31 | −23 | 1 | −131 | −52 | −21 | −1 | −20 | −21 |
| Net income | −33 | −30 | −43 | −31 | −23 | 1 | −131 | −52 | −21 | −1 | −20 | −21 |
| EPS, basic | −$0.51 | −$0.46 | −$0.65 | −$0.47 | −$0.35 | $0.01 | −$1.97 | −$0.78 | −$0.31 | −$0.01 | −$0.30 | −$0.31 |
| EPS, diluted | −$0.51 | −$0.46 | −$0.65 | −$0.47 | −$0.35 | $0.01 | −$1.97 | −$0.78 | −$0.31 | −$0.01 | −$0.30 | −$0.31 |
| Weighted average shares, basic | 65 | 65 | 65 | 65 | 66 | 66 | 66 | 67 | 68 | 68 | 68 | 68 |
| Weighted average shares, diluted | 65 | 65 | 65 | 65 | 66 | 66 | 66 | 67 | 68 | 68 | 68 | 68 |
| EBITDA | −23 | −26 | −34 | −24 | −17 | 6 | −116 | −51 | −19 | 11 | −14 | −9 |
| Depreciation & amortization | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 9 |
| EBIT | −27 | −30 | −38 | −28 | −21 | 2 | −121 | −55 | −23 | 7 | −18 | −18 |
